International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer | Zendy

Tuomo J Meretoja | Zendy; Marjut Leidenius | Zendy; Päivi Heikkilä | Zendy; Gábor Boross | Zendy; István Sejben | Zendy; Peter Regitnig | Zendy; G. Luschin-Ebengreuth | Zendy; Janez Žgajnar | Zendy; Andraž Perhavec | Zendy; Barbara Gazić | Zendy; György Lázár | Zendy; Tibor Takács | Zendy; András Vörös | Zendy; Zuhair Saidan | Zendy; R. Nadeem | Zendy; Isabella Castellano | Zendy; Anna Sapino | Zendy; Simonetta Bianchi | Zendy; Vania Vezzosi | Zendy; Emmanuel Barranger | Zendy; R. Lousquy | Zendy; Riccardo Arisio | Zendy; Maria Pia Foschini | Zendy; Shigeru Imoto | Zendy; Hiroshi Kamma | Zendy; Tove Filtenborg Tvedskov | Zendy; Niels Kroman | Zendy; Maj-Brit Jensen | Zendy; Riccardo A. Audisio | Zendy; Gábor Cserni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer

Author(s) -

Tuomo J Meretoja,

Marjut Leidenius,

Päivi Heikkilä,

Gábor Boross,

István Sejben,

Peter Regitnig,

G. Luschin-Ebengreuth,

Janez Žgajnar,

Andraž Perhavec,

Barbara Gazić,

György Lázár,

Tibor Takács,

András Vörös,

Zuhair Saidan,

R. Nadeem,

Isabella Castellano,

Anna Sapino,

Simonetta Bianchi,

Vania Vezzosi,

Emmanuel Barranger,

R. Lousquy,

Riccardo Arisio,

Maria Pia Foschini,

Shigeru Imoto,

Hiroshi Kamma,

Tove Filtenborg Tvedskov,

Niels Kroman,

Maj-Brit Jensen,

Riccardo A. Audisio,

Gábor Cserni

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs455

Subject(s) - medicine , breast cancer , sentinel node , logistic regression , receiver operating characteristic , confidence interval , axillary lymph node dissection , biopsy , sentinel lymph node , radiology , oncology , cancer , surgery

Axillary treatment of breast cancer patients is undergoing a paradigm shift, as completion axillary lymph node dissections (ALNDs) are being questioned in the treatment of patients with tumor-positive sentinel nodes. This study aims to develop a novel multi-institutional predictive tool to calculate patient-specific risk of residual axillary disease after tumor-positive sentinel node biopsy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research